Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225253380> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W4225253380 endingPage "610" @default.
- W4225253380 startingPage "610" @default.
- W4225253380 abstract "The optimal dosage of cefoperazone-sulbactam for patients with chronic kidney disease (CKD) remains unclear. This study aimed to investigate two treatment strategies of cefoperazone-sulbactam-2 g/2 g twice daily and adjusted dose according to renal function for patients with CKD. A total of 155 patients with CKD received cefoperazone-sulbactam either at a dose of 2 g/2 g twice daily (study group) or adjusted according to renal function (control group) for the treatment of acute bacterial infection. The primary outcome was the clinical response rate at day 14 and the secondary outcomes included treatment failure and all-cause death. The study group had a higher clinical response rate (80.0% vs. 65.0%) and a lower treatment failure rate (4.0% vs. 23.8%) as compared with the control group. Further multivariable analysis showed that compared with the control group, the study group had a higher clinical response rate (adjusted OR = 4.02; 95% CI, 1.49-10.81) and lower treatment failure rate (adjusted OR = 0.06; 95% CI, 0.01-0.28). In addition, no significant difference in all-cause mortality was observed between the study and the control group (adjusted OR = 1.95; 95% CI, 0.57-6.66). Finally, no significant difference was observed between the study and the control group in the risk of the adverse events (AEs)-diarrhea (p = 0.326), eosinophilia (p = 1.000), prolonged PT (p = 0.674), alteration in renal function (p = 0.938) and leukopenia (n = 0.938). In conclusion, cefoperazone-sulbactam at a dose of 2 g/2 g twice daily could achieve better clinical efficacy than the reduced dosage regimen. Additionally, this dosage did not increase the risk of AE compared to the reduced dose. Therefore, cefoperazone-sulbactam at a dose of 2 g/2 g twice daily is an effective and safe regimen for acute bacterial infection in patients with CKD." @default.
- W4225253380 created "2022-05-04" @default.
- W4225253380 creator A5008314407 @default.
- W4225253380 creator A5022398404 @default.
- W4225253380 creator A5052266233 @default.
- W4225253380 creator A5071705502 @default.
- W4225253380 date "2022-04-30" @default.
- W4225253380 modified "2023-10-18" @default.
- W4225253380 title "Optimal Dose of Cefoperazone-Sulbactam for Acute Bacterial Infection in Patients with Chronic Kidney Disease" @default.
- W4225253380 cites W1419911784 @default.
- W4225253380 cites W1984984859 @default.
- W4225253380 cites W2074738667 @default.
- W4225253380 cites W2089649437 @default.
- W4225253380 cites W2134747733 @default.
- W4225253380 cites W2565243599 @default.
- W4225253380 cites W2729161724 @default.
- W4225253380 cites W2762041370 @default.
- W4225253380 cites W2891751593 @default.
- W4225253380 cites W2904169159 @default.
- W4225253380 cites W2904691916 @default.
- W4225253380 cites W2947397099 @default.
- W4225253380 cites W2982731334 @default.
- W4225253380 cites W3006231384 @default.
- W4225253380 cites W3008674077 @default.
- W4225253380 cites W3126542935 @default.
- W4225253380 cites W3129813604 @default.
- W4225253380 cites W3172565276 @default.
- W4225253380 cites W4200045842 @default.
- W4225253380 cites W4200052801 @default.
- W4225253380 cites W4200206485 @default.
- W4225253380 doi "https://doi.org/10.3390/antibiotics11050610" @default.
- W4225253380 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35625254" @default.
- W4225253380 hasPublicationYear "2022" @default.
- W4225253380 type Work @default.
- W4225253380 citedByCount "1" @default.
- W4225253380 countsByYear W42252533802022 @default.
- W4225253380 crossrefType "journal-article" @default.
- W4225253380 hasAuthorship W4225253380A5008314407 @default.
- W4225253380 hasAuthorship W4225253380A5022398404 @default.
- W4225253380 hasAuthorship W4225253380A5052266233 @default.
- W4225253380 hasAuthorship W4225253380A5071705502 @default.
- W4225253380 hasBestOaLocation W42252533801 @default.
- W4225253380 hasConcept C126322002 @default.
- W4225253380 hasConcept C159641895 @default.
- W4225253380 hasConcept C197934379 @default.
- W4225253380 hasConcept C2776432923 @default.
- W4225253380 hasConcept C2778478555 @default.
- W4225253380 hasConcept C2778653478 @default.
- W4225253380 hasConcept C2779631663 @default.
- W4225253380 hasConcept C501593827 @default.
- W4225253380 hasConcept C71924100 @default.
- W4225253380 hasConcept C86803240 @default.
- W4225253380 hasConcept C89423630 @default.
- W4225253380 hasConcept C90924648 @default.
- W4225253380 hasConcept C94665300 @default.
- W4225253380 hasConceptScore W4225253380C126322002 @default.
- W4225253380 hasConceptScore W4225253380C159641895 @default.
- W4225253380 hasConceptScore W4225253380C197934379 @default.
- W4225253380 hasConceptScore W4225253380C2776432923 @default.
- W4225253380 hasConceptScore W4225253380C2778478555 @default.
- W4225253380 hasConceptScore W4225253380C2778653478 @default.
- W4225253380 hasConceptScore W4225253380C2779631663 @default.
- W4225253380 hasConceptScore W4225253380C501593827 @default.
- W4225253380 hasConceptScore W4225253380C71924100 @default.
- W4225253380 hasConceptScore W4225253380C86803240 @default.
- W4225253380 hasConceptScore W4225253380C89423630 @default.
- W4225253380 hasConceptScore W4225253380C90924648 @default.
- W4225253380 hasConceptScore W4225253380C94665300 @default.
- W4225253380 hasIssue "5" @default.
- W4225253380 hasLocation W42252533801 @default.
- W4225253380 hasLocation W42252533802 @default.
- W4225253380 hasLocation W42252533803 @default.
- W4225253380 hasOpenAccess W4225253380 @default.
- W4225253380 hasPrimaryLocation W42252533801 @default.
- W4225253380 hasRelatedWork W153457620 @default.
- W4225253380 hasRelatedWork W1969776961 @default.
- W4225253380 hasRelatedWork W1993243245 @default.
- W4225253380 hasRelatedWork W2060490442 @default.
- W4225253380 hasRelatedWork W2359059092 @default.
- W4225253380 hasRelatedWork W2364612406 @default.
- W4225253380 hasRelatedWork W2386678237 @default.
- W4225253380 hasRelatedWork W2396908485 @default.
- W4225253380 hasRelatedWork W2762041370 @default.
- W4225253380 hasRelatedWork W3119166003 @default.
- W4225253380 hasVolume "11" @default.
- W4225253380 isParatext "false" @default.
- W4225253380 isRetracted "false" @default.
- W4225253380 workType "article" @default.